BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37552373)

  • 1. HILPDA-mediated lipidomic remodelling promotes radiotherapy resistance in nasopharyngeal carcinoma by accelerating mitophagy.
    Zhang Y; Pang C; Zhang C; Wang Y; Wang P; Chen Y; Wang J; Hu Y; Liu C; Liang H; Xie G; Ou J
    Cell Mol Life Sci; 2023 Aug; 80(9):242. PubMed ID: 37552373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LACTB2 renders radioresistance by activating PINK1/Parkin-dependent mitophagy in nasopharyngeal carcinoma.
    Chen Q; Zheng W; Zhu L; Liu H; Song Y; Hu S; Bai Y; Pan Y; Zhang J; Guan J; Shao C
    Cancer Lett; 2021 Oct; 518():127-139. PubMed ID: 34271102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
    Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
    Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
    Ma F; Gu X; Liu JQ; Mo LH; Yang G; Geng XR; Liu ZQ; Liu ZG; Yang PC
    PLoS One; 2020; 15(3):e0229272. PubMed ID: 32119704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway.
    Miao J; Chen B; Xiao Y; Huang R; Xiao X; Lu S; Zhang L; Wang X; Ouyang Y; Chen X; Chen Q; Xiang Y; Guo X; Deng X; Wang L; Mai H; Zhao C
    Cancer Gene Ther; 2023 Sep; 30(9):1249-1259. PubMed ID: 37258811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
    He W; Jin H; Liu Q; Sun Q
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression.
    Zhou Y; Xiao Y; Liu H; Chen Q; Zhu L; Zeng L; Liu X; Pan Y; Zhang J; Fu J; Shao C
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C60-C73. PubMed ID: 38009194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma.
    Yang XZ; Chen XM; Zeng LS; Deng J; Ma L; Jin C; Wang R; Wang MH; Wen YF; Wu XL; Wang HY; Cui SZ
    Aging (Albany NY); 2020 Oct; 12(20):20380-20395. PubMed ID: 33068388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of lncRNA SNHG16 Attenuates the Proliferation and Radioresistance of Nasopharyngeal Carcinoma Cells by Mediating miR-31-5p/SFN Axis.
    Zhang W; Zhou X; Tang Z; Fu L; Zou S; Tang S
    Radiat Res; 2023 Feb; 199(2):124-131. PubMed ID: 36520963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CASC19 Enhances the Radioresistance of Nasopharyngeal Carcinoma by Regulating the miR-340-3p/FKBP5 Axis.
    Liu H; Chen Q; Zheng W; Zhou Y; Bai Y; Pan Y; Zhang J; Shao C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
    Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
    J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3'-UTR.
    Guo Y; Zhai J; Zhang J; Ni C; Zhou H
    Med Sci Monit; 2019 Apr; 25():3161-3169. PubMed ID: 31034464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
    Zhang Y; Zhang W
    Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
    Zhang P; Shao Y; Quan F; Liu L; Yang J
    Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased expression of cytokeratin 13 leads to an increase in radiosensitivity of nasopharyngeal carcinoma HNE-3 cells by upregulating ERRFI1.
    Wang H; Shi M; Wan J; Yu H
    IUBMB Life; 2023 Aug; 75(8):688-698. PubMed ID: 37070291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.